Abstract Session: Kidney - Acute Rejection
Monday September 23, 2024 from 08:00 to 09:15
Üsküdar 3
Click for details – page will open in a new window
Moderators
  • Carlos H. Diaz, Argentina
  • Prof. Kate Wyburn, Australia
Lectures
  • 205.1 A randomised controlled trial of intravenous immunoglobulin (IVIg) compared with standard of care for the treatment of chronic active antibody mediated rejection (VIPAR)
    Dr. William R Mulley, Australia
  • 205.2 Tissue-resident memory T cells in human kidney transplants have alloreactive potential
    Mr. Hector Tejeda, Netherlands
  • 205.3 Graft function stabilisation in chronic AMR: Can Tocilizumab be an option
    Dr. Abhishek Vashisth, India
  • 205.5 Not all transplant glomerulopathy related to chronic antibody-mediated rejection
    Prof. Enver Akalin, United States
  • 205.6 Desensitization-Resistant Eplet-Specific HLA Antibodies
    Dr. Erol Demir, Turkey
  • 205.7 Dynamic release of kidney-derived urinary extracellular vesicles: potential biomarkers for acute rejection in kidney transplantation
    Dr. Karin Boer, Netherlands